Specifically, KLF2 was found to be downregulated in breast cancer and was positively correlated with the expression of ER, PR, HER2, and negatively correlated with pathological grade, pathological stage, tumor size, lymph node metastases, and distant metastasis. Here, ERBB2 is linked to neoplasm.